Previous Article | Next Article 
Journal of Clinical Microbiology, March 2004, p. 1236-1242, Vol. 42, No. 3
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.3.1236-1242.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Hairpin Primers for Simplified Single-Nucleotide Polymorphism Analysis of Mycobacterium tuberculosis and Other Organisms
Manzour Hernando Hazbón* and David Alland
Division of Infectious Diseases, Department of Medicine, and the Ruy V. Lourenço Center for the Study of Emerging and Reemerging Pathogens, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07103
Received 18 August 2003/
Returned for modification 12 October 2003/
Accepted 5 December 2003

ABSTRACT
We describe a novel, simple, rapid, and highly sensitive method
to detect single-nucleotide polymorphisms (SNPs) in
Mycobacterium tuberculosis and other organisms. Amplification refractory mutation
(ARMS) SNP assays were modified by converting the SNP-detecting
linear primers in the ARMS assay to hairpin-shaped primers (HPs)
through the addition of a 5' tail complementary to the 3' end
of the linear primer. The improved ability of these primers
to detect SNPs in
M. tuberculosis was compared in a real-time
PCR with SYBR-I green dye. Linear primers resulted in incorrect
or indeterminate allele designation for 6 of the 13 SNP alleles
tested in seven different SNP assays, while HPs determined the
correct SNP in all cases. We compared the cycle threshold differences
(
Ct) between the reactions containing primer-template matches
and the reactions containing primer-template mismatches (where
a larger
Ct indicates a more robust assay). The use of HPs dramatically
improved the mean
Ct values for the SNP assays (7.6 for linear
primers and 11.2 for HPs). We designed 98 different HP assays
for SNPs previously associated with resistance to the antibiotic
isoniazid to test the large-scale utility of the HP approach.
Assay design was successful in 72.4%, 83.7%, 88.8%, and 92.9%
of the assays after one to four rounds of assay design, respectively.
HP SNP assays are simple, sensitive, robust, and inexpensive.
These advantages favor the application of this technique for
SNP assays of
M. tuberculosis and other organisms.

INTRODUCTION
Single-nucleotide polymorphism (SNP) analysis is becoming increasingly
important for studies of drug resistance, evolution, and molecular
epidemiology in
Mycobacterium tuberculosis (
2,
7,
9,
18,
20-
22),
human immunodeficiency virus (
3,
10,
15), and other organisms
(
12,
23,
26,
31,
32). High-throughput SNP analysis can be particularly
beneficial for confirming associations between specific SNPs
and a phenotype of interest, such as drug resistance. The ideal
SNP detection method should be simple to design, easy to perform
under uniform assay conditions (so that multiple SNP assays
can be performed simultaneously), easy to automate, and inexpensive.
Most approaches, including DNA sequencing and its derivations
(
9,
22), microarrays (
6), allele-specific amplification (
33),
mass spectrometry-based techniques (
27), TaqMan probes (
14),
and molecular beacons (
28), represent a tradeoff between cost,
throughput, and flexibility.
We developed an improved SNP detection method to enable us to analyze large numbers of M. tuberculosis isolates. Most causes of drug resistance in M. tuberculosis appear to be the result of SNPs in particular target genes. However, each SNP occurs at a relatively low frequency. Therefore, in the absence of large sequencing studies, it has been difficult to establish statistically valid associations between individual SNPs and resistance to a particular drug. In the case of resistance to the antibiotic isoniazid, only mutations in codon 315 of the katG gene occur with sufficient frequency. The danger of reaching conclusions after analyzing only a limited number of M. tuberculosis isolates is illustrated by the case of SNPs in codon 463 of katG and codons 269 and 312 of the kasA gene, which were originally identified as resistance associated but later shown to be common in isoniazid-susceptible isolates (1, 2, 13, 24, 25).
The amplification refractory mutation (ARMS) (17) method is an attractive starting point for designing improved SNP assays. ARMS assays differentiate among SNPs by taking advantage of the relative inability of Taq polymerase to extend primers that are mismatched to their targets at the 3' end. This technique uses two sets of PCR primers with identical "conserved" primers but variable "SNP-specific" primers. The SNP-specific primers are designed to be identical except for their 3'-end nucleotide. At the last 3' nucleotide, one SNP-specific primer is designed to be complementary to the wild-type sequence, while the other SNP-specific primer is designed to be complementary to the mutant sequence. Two PCRs are performed, one with each of the two SNP-specific primers. Under the usual circumstances, amplification is more efficient in the reaction that contains the perfectly complementary primer than in the reaction that contains the 3'-mismatched primer. Thus, the reaction with the complementary primer will contain more PCR product or, in the case of real-time PCR, will be identified by an earlier cycle threshold (Ct). This technique is a simple and inexpensive method for identifying SNPs; however, it is not always reliable (4).
We postulated that the thermodynamic properties that give stem-and-loop probes enhanced abilities to distinguish among SNP alleles (most notably demonstrated with molecular beacon probes [5, 7, 18, 19, 28]) could be used to improve the ARMS approach. Here, we demonstrate that conversion of the linear SNP-specific primers used in the ARMS assays to hairpin-shaped primers (HPs) designed with molecular beacon principles and parameters (29) results in dramatic improvements in SNP-detecting ability. These improvements have made it possible for us to detect M. tuberculosis SNPs simply, rapidly, and inexpensively.

MATERIALS AND METHODS
M. tuberculosis isolates and chromosomal DNA extraction.
Chromosomal DNA was extracted with the cetyltrimethylammonium
bromide method as described previously (
30). The reference strain
H37Rv was used as a wild-type control. Clinical isolates I-524,
M-5036, and M-5455 were used as mutant controls for
katGS315I,
katGS315N, and
katGS315T, respectively. For the remaining SNPs
tested, the isolates used are indicated in Table
1.
Real-time PCR.
All PCRs were performed in an Applied Biosystems 7900HT sequence
detector system with the 384-well block for real-time PCR. Thermal
conditions were as follows: stage 1, 95°C for 10 min, 70°C
for 30 s; stage 2, 72°C for 30 s, 95°C for 20 s, 69°C
for 30 s, lowering one degree in the last step for every cycle
during 10 cycles; and stage 3, 72°C for 30 s, 95°C for
20 s, and 60°C for 30 s, repeated 40 times. Data were collected
in the last step of stage 3 for analysis with the SDS software
version 2.0a23 (Applied Biosystems). Every well was loaded with
PCR cocktail containing 1
x Amplitaq Gold polymerase buffer,
0.15 U of Amplitaq Gold polymerase (Perkin-Elmer), 2 mM MgCl
2,
2.5 pmol of each primer, 1
x SYBR green I (Molecular Probes Inc.),
1.75 ng of ROX (6-carboxy-X-rhodamine, succinimidyl ester) (Molecular
Probes Inc.) (used as a reference dye), and either 0.1 ng of
chromosomal DNA, 10
5 molecules of the artificial template, or
an equal volume of water (no-DNA control), followed by sufficient
water to result in a final volume of 5 µl.
HP assay design.
The primers (Invitrogen or Illumina) whose sequences are shown in Table 1 were designed with the Primer Express software version 2.0 (Applied Biosystems) to produce short amplicons (30 to 90 bp) and to anneal between 60 and 65°C. A tail was added to the 5' end of the SNP-detecting primer in order to produce a stem with the 3' end of the primer. The stem was designed with mfold software (http://www.bioinfo.rpi.edu/applications/mfold/old/dna/) to have a Tm of 67 to 70°C with a free energy (
G) of between -0.5 and -2.0. Two single-stranded artificial templates (wild type and mutant) were designed to test the discriminatory power of each primer set, and chromosomal DNA of M. tuberculosis H37Rv was used as a wild-type control.
HP high-throughput assay.
We loaded 384-well plates (Applied Biosystems) with 5 µl of the SNP-specific and constant primer mix per well with a Biomek 2000 Laboratory Automation Workstation (Beckman Coulter). Plates were completely dried overnight inside a laminar-flow cabinet and kept in air-tight plastic bags at -20°C until used. We then loaded 5 µl of the PCR cocktail containing all the components except the primers per well into the microtiter plates. The plates were vortexed and then centrifuged prior to being loaded into the robot of the sequence detector system apparatus.
Comparison of linear primers and HPs.
The abilities of linear primers and HPs to distinguish between two or more SNP alleles in seven different SNP assays were compared. The principles of the HP assay are shown in Fig. 1. First, sets of linear primers for standard ARMS assays were designed with Primer Express software. Then, a second set of primers identical to the first set except that the SNP-specific primer was modified to form a stem-and-loop structure as described above were designed. Assays containing the conventional linear primers and otherwise identical assays containing the HPs were then tested for their ability to distinguish between M. tuberculosis SNPs.
Seven actual drug resistance-associated SNPs present in
M. tuberculosis were tested with
M. tuberculosis chromosomal DNA to ensure that
the results would be applicable in the subsequent investigations.
Each assay was performed in quadruplicate and the average
Ct values for each quadruplicate set were calculated. Corresponding
linear primer and HP assays were compared on two characteristics:
the ability to designate the correct SNP (versus an incorrect
or indeterminate assignment) and the average cycle threshold
difference (
Ct) between the reactions containing primer-template
matches and the reactions containing primer-template mismatches
(where a larger
Ct indicates a more robust assay). Assays were
considered indeterminate if the
Ct was lower than 5.
HP approach for loci containing multiple alleles.
A single codon can contain more than two SNP alleles. This is the case for position 315 in the katG gene of M. tuberculosis, which is the most common position mutated in isoniazid-resistant clinical isolates (20). The ability of the HP assay to test for four possible alleles at this position was investigated. A single wild-type HP primer and three different mutant HP primers were designed to be complementary to each katG315 allele. The HPs were then tested in assays with chromosomal M. tuberculosis DNA containing each mutation.

RESULTS
Comparison of linear primer and HP.
We compared the abilities of linear primers and HPs to detect
seven isoniazid resistance-associated SNPs present in the chromosome
of six
M. tuberculosis clinical isolates. The linear primer
assay identified the correct SNP in only 7 of 13 assays (producing
one incorrect and five indeterminate results), while the HP
assay identified the correct SNP in all 13 assays, demonstrating
the superiority of this format (Fig.
2A and B, red triangles).
Furthermore, the HP assay appeared to be more sensitive for
SNPs, as the
Ct values were greater in the HP assays than in
the linear primer assays (Table
2).
View this table:
[in this window]
[in a new window]
|
TABLE 2. Average Cts of seven SNP assays with different primer sets on templates consisting of chromosomal DNA of M. tuberculosisa
|
HP comparison with linearized HPs and extended linearized HPs.
We postulated that the enhanced ability of the HP configuration
might be due to the extended 5' tail of the SNP-specific primer
rather than to the actual stem-and-loop design. To further investigate
this possibility, "linearized" HPs (LHPs) were created by mutating
the 5' tail of each HP primer so that it could no longer form
a stem with the 3' end. The LHPs were designed so that no new
secondary structures were formed and they had the same GC content
as the HPs. Each SNP assay was repeated with LHP sets. Figure
2C demonstrates that the performance of the LHP assays was intermediate
between that of the linear primers and HPs. LHP assays produced
only one indeterminate result, but the
Ct values averaged 1.7
cycles less than those of the HP assays (Table
2).
To determine if further lengthening of the 5' tail would continue to enhance the ability of LHPs to distinguish among SNPs, a corresponding set of "extended" LHPs (ELHPs) were created by doubling the length of each 5' tail. The performance of assays with ELHPs was compared with those of the other primers (Fig. 2D). We found that ELHP assays produced results that were similar to those of LHP assays, with one indeterminate result out of 13 (red triangles in Fig. 2). Notably, assays with ELHPs had improved
Ct values, with an average
Ct that was equivalent to the average
Ct of reactions containing HPs (Table 2). However, the
Ct values of individual HP assays fell within a narrower range than the
Cts of the ELHPs, suggesting that the HP-based assays remained advantageous.
Evaluation of the insertion of a secondary mismatch.
The effect of inserting additional base pair mismatches into the HPs was tested. We postulated that a secondary base pair mismatch would decrease the affinity of the mismatched primers to their target and result in a later Ct for the mismatched reactions, an observation previously reported by others for linear primers (8). A secondary mismatch was inserted into each primer either towards the center of the loop or at the end of the stem. Mismatches were designed so that total GC content was maintained. The results (blue diamonds in Fig. 2) indicate that the secondary mismatches resulted in later Cts in both match and mismatch reactions and led to
Ct values that were improved by 1.1, 0.2, 2.1, and 0.8 cycles for the linear primer, HP, LHP, and ELHP, respectively. The number of rejected assays did not vary with the secondary mismatch except for the linear primers, where only four reactions were rejected (one incorrect and three indeterminate results) (data not shown). The incorporation of a secondary mismatch can also play an important role during HP design. The mismatch confers flexibility on the design process and can be used to avoid undesired secondary structures.
HP approach for loci containing multiple alleles.
In order to evaluate the ability of the HP assay to detect several SNP alleles at the same position, we designed HPs for four possible alleles at position 315 in the katG gene of M. tuberculosis and tested the assay with chromosomal M. tuberculosis DNAs containing each mutation. The results (Fig. 3) show that the well containing the fully complementary HP always had the earlier Ct than the wells containing the mismatched HPs.
Success rate of large-scale HP assay design.
We attempted to design 98 HP assays for 207 different
M. tuberculosis SNPs at 98 different polymorphic sites previously associated
with resistance to isoniazid to test the utility of the HP approach
in large-scale SNP analysis. Each assay was tested on chromosomal
DNA from
M. tuberculosis H37Rv (wild-type control) and both
artificial templates. Mutant chromosomal DNA was also used when
available. We succeeded in creating 91 functional HP assays
(most of which included a secondary mutation) that detected
191 SNPs in the
katG,
kasA,
ahpC,
inhA,
mabA, and
ndh genes
of
M. tuberculosis. Assays that detected insertions and deletions
were developed with the same parameters. Design success rates
as a function of number of design attempts are shown in Table
3. We were unable to design seven (7.1%) assays to detect 16
alleles after two to four attempts.
Sensitivity of the HP assay.
We investigated the sensitivity of the assays in terms of the
amount of chromosomal DNA required per assay. Most assays gave
consistent results with less than 0.05 ng of chromosomal DNA
per well; however, we found that 0.1 ng/well resulted in smoother
amplification curves (data not shown). The extreme sensitivity
of our assay may be due to our design protocol, which favors
very short amplicons.

DISCUSSION
HP assay offers several advantages for individual laboratories
planning to perform SNP analysis on a medium scale (hundreds
to thousands of assays per day). The design and setup of the
assays are straightforward. SNP detection is integrated with
the PCR step, experimental complexity is dramatically reduced,
and it is easy to automate. Except for the cost of the real-time
PCR apparatus, we found that the material costs of the technique
were low. Based on 5-µl/well reactions, we calculated
the reagent cost to be approximately US$0.05 per well (of which
US$0.043 is attributable to the cost of TaqGold polymerase)
and plasticware costs to be an additional US$0.02 per well,
totaling US$0.07 per well, or US$0.14 per SNP assay. The initial
investment in a real-time PCR instrument and other laboratory
equipment would add considerably to these costs; however, such
equipment is becoming standard in many research centers.
The HP assays enabled most alleles to be easily discriminated under a single standard condition. The efficiency of many of these assays could likely have been improved by individualizing the PCR conditions for each primer set. However, our aim was to unify conditions so that different SNP assays could be performed simultaneously. We found that ELHPs and HPs had similar performance characteristics, although HPs resulted in more consistent
Cts and are preferred by our laboratory. It is possible that the additional nucleotides added to the 5' end of the ELHPs result in secondary structures that mimic HP thermodynamics and that the variability of the
Cts in ELHP assays is the result of differences in these unplanned structures. Previous reports (11, 16) have shown that HPs (which are not designed to detect SNPs) improve the specificity of PCR assays by decreasing mispriming and primer-dimer formation compared to linear primers. This feature may be an added benefit of the HP design for SNP assays. Our assays were tested with purified DNA. It is possible that HP assays would perform less well if tested on crude DNA preparations. However, the assay is likely to perform well with most common DNA purification techniques.

ACKNOWLEDGMENTS
This research was supported by NIH grant AI 46669.
We thank Qingge Li and Sanjay Tyagi for invaluable scientific advice.

FOOTNOTES
* Corresponding author. Mailing address: Division of Infectious Diseases, Department of Medicine, and the Ruy V. Lourenço Center for the Study of Emerging and Reemerging Pathogens, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, 185 South Orange Ave., MSB A900, Newark, NJ 07103. Phone: (973) 972-2175. Fax: (973) 972-0713. E-mail:
hazbonmh{at}umdnj.edu.


REFERENCES
1 - Abate, G., S. E. Hoffner, V. O. Thomsen, and H. Miorner. 2001. Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG. Eur. J. Clin. Microbiol. Infect. Dis. 20:329-333.[CrossRef][Medline]
2 - Alland, D., T. S. Whittam, M. B. Murray, M. D. Cave, M. H. Hazbon, K. Dix, M. Kokoris, A. Duesterhoeft, J. A. Eisen, C. M. Fraser, and R. D. Fleischmann. 2003. Modeling bacterial evolution with comparative-genome-based marker systems: application to Mycobacterium tuberculosis evolution and pathogenesis. J. Bacteriol. 185:3392-3399.[Abstract/Free Full Text]
3 - Ameyaw, M. M., F. Regateiro, T. Li, X. Liu, M. Tariq, A. Mobarek, N. Thornton, G. O. Folayan, J. Githang'a, A. Indalo, D. Ofori-Adjei, D. A. Price-Evans, and H. L. McLeod. 2001. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics 11:217-221.[CrossRef][Medline]
4 - Ayyadevara, S., J. J. Thaden, and R. J. Shmookler Reis. 2000. Discrimination of primer 3'-nucleotide mismatch by taq DNA polymerase during polymerase chain reaction. Anal. Biochem. 284:11-18.[CrossRef][Medline]
5 - Bonnet, G., S. Tyagi, A. Libchaber, and F. R. Kramer. 1999. Thermodynamic basis of the enhanced specificity of structured DNA probes. Proc. Natl. Acad. Sci. USA 96:6171-6176.[Abstract/Free Full Text]
6 - Chee, M., R. Yang, E. Hubbell, A. Berno, X. C. Huang, D. Stern, J. Winkler, D. J. Lockhart, M. S. Morris, and S. P. Fodor. 1996. Accessing genetic information with high-density DNA arrays. Science 274:610-614.[Abstract/Free Full Text]
7 - El-Hajj, H. H., S. A. Marras, S. Tyagi, F. R. Kramer, and D. Alland. 2001. Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J. Clin. Microbiol. 39:4131-4137.[Abstract/Free Full Text]
8 - Fan, X. Y., Z. Y. Hu, F. H. Xu, Z. Q. Yan, S. Q. Guo, and Z. M. Li. 2003. Rapid detection of rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis isolates in Shanghai by using the amplification refractory mutation system. J. Clin. Microbiol. 41:993-997.[Abstract/Free Full Text]
9 - Gutacker, M. M., J. C. Smoot, C. A. Migliaccio, S. M. Ricklefs, S. Hua, D. V. Cousins, E. A. Graviss, E. Shashkina, B. N. Kreiswirth, and J. M. Musser. 2002. Genome-wide analysis of synonymous single nucleotide polymorphisms in Mycobacterium tuberculosis complex organisms: resolution of genetic relationships among closely related microbial strains. Genetics 162:1533-1543.[Abstract/Free Full Text]
10 - Hanna, G. J., V. A. Johnson, D. R. Kuritzkes, D. D. Richman, A. J. Brown, A. V. Savara, J. D. Hazelwood, and R. T. D'Aquila. 2000. Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine. J. Infect. Dis. 181:904-911.[CrossRef][Medline]
11 - Kaboev, O. K., L. A. Luchkina, A. N. Tret'iakov, and A. R. Bahrmand. 2000. PCR hot start with primers with the structure of molecular beacons (hairpin-like structure). Nucleic Acids Res. 28:E94.
12 - Kota, R., R. K. Varshney, T. Thiel, K. J. Dehmer, and A. Graner. 2001. Generation and comparison of EST-derived SSRs and SNPs in barley (Hordeum vulgare L.). Hereditas 135:145-151.[CrossRef][Medline]
13 - Lee, A. S., I. H. Lim, L. L. Tang, A. Telenti, and S. Y. Wong. 1999. Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore. Antimicrob. Agents Chemother. 43:2087-2089.[Abstract/Free Full Text]
14 - Lee, L. G., K. J. Livak, B. Mullah, R. J. Graham, R. S. Vinayak, and T. M. Woudenberg. 1999. Seven-color, homogeneous detection of six PCR products. BioTechniques 27:342-349.[Medline]
15 - Martinez-Picado, J., K. Morales-Lopetegi, T. Wrin, J. G. Prado, S. D. Frost, C. J. Petropoulos, B. Clotet, and L. Ruiz. 2002. Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptions. AIDS 16:895-899.[CrossRef][Medline]
16 - Nazarenko, I., B. Lowe, M. Darfler, P. Ikonomi, D. Schuster, and A. Rashtchian. 2002. Multiplex quantitative PCR with self-quenched primers labeled with a single fluorophore. Nucleic Acids Res. 30:E37.
17 - Newton, C. R., A. Graham, L. E. Heptinstall, S. J. Powell, C. Summers, N. Kalsheker, J. C. Smith, and A. F. Markham. 1989. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res. 17:2503-2516.[Abstract/Free Full Text]
18 - Piatek, A. S., A. Telenti, M. R. Murray, H. El-Hajj, W. R. Jacobs, Jr., F. R. Kramer, and D. Alland. 2000. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations with molecular beacons: implications for rapid susceptibility testing. Antimicrob. Agents Chemother. 44:103-110.[Abstract/Free Full Text]
19 - Piatek, A. S., S. Tyagi, A. C. Pol, A. Telenti, L. P. Miller, F. R. Kramer, and D. Alland. 1998. Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis. Nat. Biotechnol. 16:359-363.[CrossRef][Medline]
20 - Ramaswamy, S., and J. M. Musser. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuberc. Lung Dis. 79:3-29.[CrossRef][Medline]
21 - Ramaswamy, S. V., A. G. Amin, S. Goksel, C. E. Stager, S. J. Dou, H. El Sahly, S. L. Moghazeh, B. N. Kreiswirth, and J. M. Musser. 2000. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 44:326-336.[Abstract/Free Full Text]
22 - Ramaswamy, S. V., R. Reich, S. J. Dou, L. Jasperse, X. Pan, A. Wanger, T. Quitugua, and E. A. Graviss. 2003. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 47:1241-1250.[Abstract/Free Full Text]
23 - Redd, A. J., J. Roberts-Thomson, T. Karafet, M. Bamshad, L. B. Jorde, J. M. Naidu, B. Walsh, and M. F. Hammer. 2002. Gene flow from the Indian subcontinent to Australia: evidence from the Y chromosome. Curr. Biol. 12:673-677.[CrossRef][Medline]
24 - Saint-Joanis, B., H. Souchon, M. Wilming, K. Johnsson, P. M. Alzari, and S. T. Cole. 1999. Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis. Biochem. J. 338:753-760.
25 - Sreevatsan, S., X. Pan, K. E. Stockbauer, N. D. Connell, B. N. Kreiswirth, T. S. Whittam, and J. M. Musser. 1997. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc. Natl. Acad. Sci. USA 94:9869-9874.[Abstract/Free Full Text]
26 - Suliman-Pollatschek, S., K. Kashkush, H. Shats, J. Hillel, and U. Lavi. 2002. Generation and mapping of AFLP, SSRs and SNPs in Lycopersicon esculentum. Cell. Mol. Biol. Lett. 7:583-597.[Medline]
27 - Tost, J., O. Brandt, F. Boussicault, D. Derbala, C. Caloustian, D. Lechner, and I. G. Gut. 2002. Molecular haplotyping at high throughput. Nucleic Acids Res. 30:E96.
28 - Tyagi, S., D. P. Bratu, and F. R. Kramer. 1998. Multicolor molecular beacons for allele discrimination. Nat. Biotechnol. 16:49-53.[CrossRef][Medline]
29 - Tyagi, S., and F. R. Kramer. 1996. Molecular beacons: probes that fluoresce upon hybridization. Nat. Biotechnol. 14:303-308.[CrossRef][Medline]
30 - van Embden, J. D., M. D. Cave, J. T. Crawford, J. W. Dale, K. D. Eisenach, B. Gicquel, P. Hermans, C. Martin, R. McAdam, T. M. Shinnick, et al. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31:406-409.[Abstract/Free Full Text]
31 - Vignal, A., D. Milan, M. SanCristobal, and A. Eggen. 2002. A review on SNP and other types of molecular markers and their use in animal genetics. Genet. Sel. Evol. 34:275-305.[CrossRef][Medline]
32 - Wagenaar, T. R., V. T. Chow, C. Buranathai, P. Thawatsupha, and C. Grose. 2003. The out of Africa model of varicella-zoster virus evolution: single nucleotide polymorphisms and private alleles distinguish Asian clades from European/North American clades. Vaccine 21:1072-1081.[CrossRef][Medline]
33 - Waterfall, C. M., and B. D. Cobb. 2001. Single tube genotyping of sickle cell anaemia with PCR-based SNP analysis. Nucleic Acids Res. 29:E119.
Journal of Clinical Microbiology, March 2004, p. 1236-1242, Vol. 42, No. 3
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.3.1236-1242.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Hazbon, M. H., Motiwala, A. S., Cavatore, M., Brimacombe, M., Whittam, T. S., Alland, D.
(2008). Convergent Evolutionary Analysis Identifies Significant Mutations in Drug Resistance Targets of Mycobacterium tuberculosis. Antimicrob. Agents Chemother.
52: 3369-3376
[Abstract]
[Full Text]
-
Chakravorty, S., Aladegbami, B., Motiwala, A. S., Dai, Y., Safi, H., Brimacombe, M., Helb, D., Alland, D.
(2008). Rifampin Resistance, Beijing-W Clade-Single Nucleotide Polymorphism Cluster Group 2 Phylogeny, and the Rv2629 191-C Allele in Mycobacterium tuberculosis Strains. J. Clin. Microbiol.
46: 2555-2560
[Abstract]
[Full Text]
-
Riordan, J. T., Viswanath, S. B., Manning, S. D., Whittam, T. S.
(2008). Genetic Differentiation of Escherichia coli O157:H7 Clades Associated with Human Disease by Real-Time PCR. J. Clin. Microbiol.
46: 2070-2073
[Abstract]
[Full Text]
-
Manning, S. D., Motiwala, A. S., Springman, A. C., Qi, W., Lacher, D. W., Ouellette, L. M., Mladonicky, J. M., Somsel, P., Rudrik, J. T., Dietrich, S. E., Zhang, W., Swaminathan, B., Alland, D., Whittam, T. S.
(2008). From the Cover: Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc. Natl. Acad. Sci. USA
105: 4868-4873
[Abstract]
[Full Text]
-
Brimacombe, M., Hazbon, M., Motiwala, A. S., Alland, D.
(2007). Antibiotic Resistance and Single-Nucleotide Polymorphism Cluster Grouping Type in a Multinational Sample of Resistant Mycobacterium tuberculosis Isolates. Antimicrob. Agents Chemother.
51: 4157-4159
[Abstract]
[Full Text]
-
Alland, D., Lacher, D. W., Hazbon, M. H., Motiwala, A. S., Qi, W., Fleischmann, R. D., Whittam, T. S.
(2007). Role of Large Sequence Polymorphisms (LSPs) in Generating Genomic Diversity among Clinical Isolates of Mycobacterium tuberculosis and the Utility of LSPs in Phylogenetic Analysis. J. Clin. Microbiol.
45: 39-46
[Abstract]
[Full Text]
-
Hazbon, M. H., Brimacombe, M., Bobadilla del Valle, M., Cavatore, M., Guerrero, M. I., Varma-Basil, M., Billman-Jacobe, H., Lavender, C., Fyfe, J., Garcia-Garcia, L., Leon, C. I., Bose, M., Chaves, F., Murray, M., Eisenach, K. D., Sifuentes-Osornio, J., Cave, M. D., Ponce de Leon, A., Alland, D.
(2006). Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosis.. Antimicrob. Agents Chemother.
50: 2640-2649
[Abstract]
[Full Text]
-
Talaue, M. T., Venketaraman, V., Hazbon, M. H., Peteroy-Kelly, M., Seth, A., Colangeli, R., Alland, D., Connell, N. D.
(2006). Arginine Homeostasis in J774.1 Macrophages in the Context of Mycobacterium bovis BCG Infection. J. Bacteriol.
188: 4830-4840
[Abstract]
[Full Text]
-
Alix, E., Godreuil, S., Blanc-Potard, A.-B.
(2006). Identification of a Haarlem Genotype-Specific Single Nucleotide Polymorphism in the mgtC Virulence Gene of Mycobacterium tuberculosis.. J. Clin. Microbiol.
44: 2093-2098
[Abstract]
[Full Text]
-
Zhang, W., Qi, W., Albert, T. J., Motiwala, A. S., Alland, D., Hyytia-Trees, E. K., Ribot, E. M., Fields, P. I., Whittam, T. S., Swaminathan, B.
(2006). Probing genomic diversity and evolution of Escherichia coli O157 by single nucleotide polymorphisms. Genome Res
16: 757-767
[Abstract]
[Full Text]
-
Filliol, I., Motiwala, A. S., Cavatore, M., Qi, W., Hazbon, M. H., Bobadilla del Valle, M., Fyfe, J., Garcia-Garcia, L., Rastogi, N., Sola, C., Zozio, T., Guerrero, M. I., Leon, C. I., Crabtree, J., Angiuoli, S., Eisenach, K. D., Durmaz, R., Joloba, M. L., Rendon, A., Sifuentes-Osornio, J., Ponce de Leon, A., Cave, M. D., Fleischmann, R., Whittam, T. S., Alland, D.
(2006). Global Phylogeny of Mycobacterium tuberculosis Based on Single Nucleotide Polymorphism (SNP) Analysis: Insights into Tuberculosis Evolution, Phylogenetic Accuracy of Other DNA Fingerprinting Systems, and Recommendations for a Minimal Standard SNP Set. J. Bacteriol.
188: 759-772
[Abstract]
[Full Text]
-
Hazbon, M. H., Bobadilla del Valle, M., Guerrero, M. I., Varma-Basil, M., Filliol, I., Cavatore, M., Colangeli, R., Safi, H., Billman-Jacobe, H., Lavender, C., Fyfe, J., Garcia-Garcia, L., Davidow, A., Brimacombe, M., Leon, C. I., Porras, T., Bose, M., Chaves, F., Eisenach, K. D., Sifuentes-Osornio, J., Ponce de Leon, A., Cave, M. D., Alland, D.
(2005). Role of embB Codon 306 Mutations in Mycobacterium tuberculosis Revisited: a Novel Association with Broad Drug Resistance and IS6110 Clustering Rather than Ethambutol Resistance. Antimicrob. Agents Chemother.
49: 3794-3802
[Abstract]
[Full Text]
-
Boniotto, M., Hazbon, M. H., Jordan, W. J., Lennon, G. P., Eskdale, J., Alland, D., Gallagher, G.
(2004). Novel Hairpin-Shaped Primer Assay To Study the Association of the -44 Single-Nucleotide Polymorphism of the DEFB1 Gene with Early-Onset Periodontal Disease. CVI
11: 766-769
[Abstract]
[Full Text]
-
Varma-Basil, M., El-Hajj, H., Marras, S. A.E., Hazbon, M. H., Mann, J. M., Connell, N. D., Kramer, F. R., Alland, D.
(2004). Molecular Beacons for Multiplex Detection of Four Bacterial Bioterrorism Agents. Clin. Chem.
50: 1060-1062
[Full Text]